A randomized, controlled, multicenter clinical trial of Fruquintinib combined with TAS-102 with Fruquintinib in the treatment of advanced metastatic colorectal cancer with standard treatment failure
收藏NIAID Data Ecosystem2026-03-12 收录
官方服务：
资源简介：
Interventions: Experimental group:Give fruquintinib combined with TAS-102;Control Group:fruquintinib Primary outcome(s): Progression-free survival Study Design: Parallel
创建时间：
2021-09-15
